Announcements

Orthofix Medical Inc. filed a Form 8-K with the SEC on August 5, 2026, announcing the release of its financial results for the second quarter ended June 30, 2026, via a press release furnished as Exhibit 99.1.

Orthofix Medical Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing net sales, operating losses, and balance sheet data for the three and six months ended June 30, 2026.

Lineage, Inc. filed a current report on Form 8-K on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, along with supplemental earnings materials made available on its website.

Q32 Bio Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission, disclosing its financial condition, risk factors, and operational status as a clinical-stage biopharmaceutical company.

Entrada Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the fiscal quarter ended June 30, 2026.

Kymera Therapeutics, Inc. filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, disclosing its financial position and operational status as a clinical-stage biopharmaceutical company.

Shake Shack Inc. filed its Form 10-Q with the SEC on August 5, 2026, covering the quarterly period ended July 1, 2026, and reporting Shack sales of $403,437 thousand for the thirteen weeks ended on that date.